Madeline is a first-generation college student, joining the Notre Dame family in August 2012. She studied Science-Business during her undergrad (a trans-disciplinary Bachelors of Science degree with a heavy concentration in business electives) with the original intention of medical school post-graduation. After hearing David Murphy speak to her physics class about the ESTEEM program during her Junior year, she quickly re-aligned her future plans and applied Early Admission before her Senior year even began.
While in the ESTEEM Program, Madeline hopes to even further contribute to the world of rare and orphan disease research. Her thesis project is partnered with industry sponsor Horizon Pharma, a large biopharmaceutical company with U.S. operations based in Chicago and will be an analysis of a new therapeutic entity targeted for orphan disease use.
The most fulfilling portion of Madeline's undergraduate tenure was during her final two and a half years, when she became engrossed in rare disease research at the Boler-Parseghian Center for Rare and Neglected Diseases. Under the guidance of her mentor, Director Kasturi Haldar, Madeline received several grants, first-authored a novel case study to Pediatrics journal, and most recently, won second prize at the National Institutes of Health for an undergraduate research challenge.
In addition to her thesis work, Madeline is excited to have been selected as a Venture Intern for enFocus, which identifies local problems as opportunities for creative solutions. As an Intern, she will develop an investable social innovation for a critical issue in South Bend. Her ambition is to ultimately scale this venture to the Midwest and then nationally.